Direct-acting antivirals used in hcv-related liver disease do not affect thyroid function and autoimmunity

HIGHLIGHTS

• who: R. Rodia from the Endocrinology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Azienda Ospedaliero-Universitaria di Cagliari, SS, Bivio per Sestu, Monserrato, Cagliari, Italy have published the research work: Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity, in the Journal: (JOURNAL)
• what: The authors provide evidence that non-autoimmune subclinical thyroid dysfunction potentially induced by HCV infection may improve after viral clearance with DAAs therapy.
• future: Larger multicentric controlled studies are needed to confirm the clinical relevance of the research . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.